3-Methylflavone-8-carboxylic acid (CAS No: 3468-01-7) serves as a critical pharmaceutical building block in the API intermediates market, particularly as the primary precursor for the antispasmodic agent Flavoxate, where a high purity fine chemicals grade of 99% is essential to mitigate downstream impurity carry-over. MFCA is currently witnessing significant integration into custom synthesis services as CDMO growth drives the demand for specialized flavonoid derivatives that exhibit targeted phosphodiesterase inhibition and smooth muscle relaxation properties. 3-Methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylic acid is increasingly prioritized by manufacturers navigating global sourcing shifts who require a reliable bulk chemical supplier capable of providing rigorous regulatory compliance and comprehensive analytical documentation for advanced drug development. We are an globally established 3-Methylflavone-8-carboxylic acid intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 3-Methylflavone-8-carboxylic acid COA/TDS/SDS region-specific regulatory support, reliable lead times, and worldwide supply chain capabilities.